The Ministry of Health is advising the public of the voluntary recall of one lot of Mylan’s Daptomycin for injection ( 500 mg/vial ), due to the presence of particulate matter found.

Daptomycin for injection is an injectable antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bloodstream infections (bacteremia) in adult patients.

Mylan NV has advised that its US – based Mylan Institutional LLC business is conducting a voluntary nationwide recall of the batch distributed to wholesalers and retail pharmacies in the US between April 2020 and May 2020.

The recalled batch is as follows:

NDC #

67457-813-50

Material Description

Daptomycin for Injection

Strength

500 mg/vial

Size

20mL vial

Lot No

7605112

Expiry

October 2021

While at this time there are no registered brands of this product approved for use in Trinidad and Tobago, the Ministry of Health is advising that distributors/retailers that may have the product which is being recalled, should immediately cease further distribution or dispensing.

Furthermore, the Ministry said it is highly recommended that consumers who are in possession of any brand of this pharmaceutical should not utilise the medication and should contact the Office of the Drug Inspectorate via 627-0046 or the Office of the Principal Pharmacist via 625-6049 or at principal.pharmacist@health.gov.tt.

Additional information can also be obtained by contacting the offices above.

The Ministry of Health added that it will continue to monitor the situation and advise the population as necessary.

Source: https://www.looptt.com/content/ministry-advises-recall-one-lot-daptomycin-injection